ARIZ Precision Medicine

ARIZ Precision Medicine is a pre-clinical stage company based in Davis, California, with 5 employees. They focus on developing novel cancer therapies. ARIZ Precision Medicine specializes in developing siRNA constructs and innovative drug delivery nanotechnologies to target and destroy cancer cells with PRDM abnormalities. Their approach aims to selectively eliminate cancer cells while sparing healthy cells. They have conducted proof-of-principle studies demonstrating the effectiveness of their technology against various cancer types, including breast, colon, lung, and myeloma cancers. The company differentiates itself through its proprietary siRNA constructs and innovative drug delivery nanotechnologies, focusing on targeting "undruggable" cancer drivers like the PRDM gene family. ARIZ aims to leverage its research findings to secure strategic partnerships with pharmaceutical companies, facilitating the advancement of its drug candidates from pre-clinical testing to clinical trials and eventual market availability. For more information, visit ARIZ Precision Medicine's website at arizbio.com.